News + Filings Holdings
All 13F 13D/G Other
|
Broadfin Capital, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/24/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Zyla Life Sciences |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 4.6% stake in Aclaris Therapeutics, Inc. |
02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/15/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 12.9% stake in Novelion Therapeutics Inc. |
10/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/22/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Aratana Therapeutics, Inc. |
02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 4.8% stake in Iovance Biotherapeutics, Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 9.6% stake in Adamas Pharmaceuticals Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 6.6% stake in Sierra Oncology, Inc. |
02/07/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Egalet Corporation |
01/22/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 14.9% stake in Aratana Therapeutics, Inc. |
12/27/2018 |
SC 13G/A
| Broadfin Capital, LLC reports a 10% stake in Novelion Therapeutics Inc. |
11/28/2018 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Corium International, Inc. |
|
|
|